Evidence map›Paper›PMID 12175338›Full record

ArticleThe Biochemical journal2002

Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramides.

Murugesapillai Mylvaganam, Henrik C Hansen, Beth Binnington, Göran Magnusson, Per-Georg Nyholm, Clifford A Lingwood

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 14 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Murugesapillai MylvaganamDivision of Infection, Immunity, Injury and Repair, Research Institute, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Henrik C Hansen
Beth Binnington
Göran Magnusson
Per-Georg Nyholm
Clifford A Lingwood
Hospital for Sick Children · CAUniversity of Gothenburg · SEUniversity of Toronto · CA

Funding

SOLUBLE RECEPTOR ANALOGS TO INHIBIT VEROTOXIN BINDINGR01DK052098 · NIDDK · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI LINGWOOD, CLIFFORD A · 1997 to 1999
–
NIDDK NIH HHS R01 DK52098
6 · The paper itself

Abstract

Specific hydroxy groups of the terminal disaccharide unit of globotriaosyl ceramide (Gb(3)Cer) were identified from binding studies with deoxyGb(3)Cer and verotoxins (VTs) [Nyholm, Magnusson, Zheng, Norel, Binnington-Boyd and Lingwood (1996) Chem. Biol. 3, 263-275]. Four such hydroxy groups (2", 4", 6" and 6') were each substituted with an amino group and the corresponding deoxyamino globotrioses were conjugated to a ceramide-like aglycone which contained an adamantyl group instead of an acyl chain. Such aglycone modification significantly enhanced the water-solubility of the glycoconjugates [Mylvaganam and Lingwood (1999) Biochem. Biophys. Res. Commun. 257, 391-394]. The inhibitory potential of these soluble aminodeoxy conjugates on the binding of VT(1) to Gb(3)Cer immobilized on an ELISA plate was evaluated. Only the 2" and the 6' deoxyamino conjugates were effective inhibitors (IC(50) 10 microM); the 4" and 6" conjugates were ineffective up to 10 mM. To evaluate the importance of incorporating a rigid adamantyl hydrocarbon group into the ceramide aglycone, globotriaose was conjugated to a t- butylacetamido or an adamantaneacetamido aglycone. By similar ELISAs, only the adamantaneacetamido conjugate inhibited the binding of VT(1) to Gb(3)Cer. When deoxyamino conjugates were adsorbed to silica on TLC plates, only the 2" and 6" conjugates bound VT(1) and VT(2). By a similar TLC assay, acetamido derivatives of 2" and 6' deoxyamino conjugates showed less binding to VT(1) and VT(2). Neither the crystallographically determined structure of the VT(1)-globotriaose complex nor modelling studies fully explain the binding patterns shown by these deoxyamino glycoconjugates. Enhanced solvation of the ammonium group of the deoxyamino conjugate could enforce greater constraints in the binding interactions.

Indexed as

Binding SitesChromatography, Thin LayerDose-Response Relationship, DrugEnzyme-Linked Immunosorbent AssayGlycolipidsHemolytic-Uremic SyndromeHumansInhibitory Concentration 50KidneyModels, ChemicalModels, MolecularOligosaccharidesProtein Structure, TertiaryShiga ToxinsTrihexosylceramidesglobotriaosylceramideGlycolipidsOligosaccharidesShiga ToxinsTrihexosylceramides

Identifiers

PMID12175338
PMCPMC1223022
OpenAlexW2002296874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.